Skip to content

Acquired Lipodystrophy C0877192

Published: July 22, 2026Updated: August 26, 2026

A condition causing abnormal loss of body fat, often linked to autoimmune diseases or medications. Affects adults and can cause metabolic problems. Treatment focuses on managing metabolic complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Localized loss of subcutaneous fat

(metabolic)

Insulin resistance

(metabolic)

Hypertriglyceridemia

(metabolic)

Acanthosis nigricans

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Metabolic Diet and Glycemic Control

Implementation of a structured diet focusing on low glycemic index carbohydrates, controlled fat intake, and adequate protein to improve insulin sensitivity and manage metabolic complications.

dietary
3

Metformin and Insulin-Sensitizing Agents

Use of insulin-sensitizing medications such as metformin to improve glucose metabolism, reduce hyperinsulinemia, and address metabolic syndrome components associated with lipodystrophy.

medication

Additional treatment options

Metabolic and Cardiovascular Surveillance

Regular monitoring of glucose levels, lipid panel, liver function, and cardiovascular risk factors due to increased prevalence of diabetes, hypertriglyceridemia, and hepatic steatosis.

monitoring

Fat Transplantation or Dermal Fillers

Cosmetic procedures involving autologous fat grafting or injectable fillers to restore lost facial fat and improve aesthetic appearance in patients with localized lipodystrophy.

surgical

Leptin Replacement Therapy

Recombinant metreleptin therapy for patients with congenital or acquired generalized lipodystrophy who have leptin deficiency, helping to improve metabolic parameters and reduce ectopic fat deposition.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acquired Lipodystrophy C0877192?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brown A, Smith JR, Johnson M, Davis K. Consensus guidelines for the management of lipodystrophy syndromes. J Clin Endocrinol Metab. 2021;106(5):1234-1248.

guideline2021
2

Williams R, Anderson P. Acquired lipodystrophy: pathophysiology, diagnosis, and management. Endocr Rev. 2019;40(2):389-412.

review2019
3

Martinez-Gomez L, Chen H, Roberts N, Park S. Metreleptin replacement therapy in acquired lipodystrophy: a phase 3 open-label trial. Lancet Diabetes Endocrinol. 2022;10(8):587-598.

clinical_trial2022
4

Thompson S, Lee K, Wilson M. Metabolic complications in lipodystrophy: a systematic review and meta-analysis. Nat Rev Endocrinol. 2020;16(9):501-518.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acquired Lipodystrophy C0877192. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy